In studies reported here, we have investigated the interaction of transcription factors TCF21 and AP-1 at loci identified by GWAS to regulate risk for the CAD phenotype, focusing on 15q22.33 and 9p21.3. This evidence concerns the gene TCF21 and coronary artery disorder.